FGFR1 fusion
|
Cholangiocarcinoma
|
FGFR1 fusion
|
Cholangiocarcinoma
|
erdafitinib Sensitive: C3 – Early Trials
|
erdafitinib Sensitive: C3 – Early Trials
|
FGFR1 fusion
|
Solid Tumor
|
FGFR1 fusion
|
Solid Tumor
|
Debio 1347 Sensitive: C3 – Early Trials
|
Debio 1347 Sensitive: C3 – Early Trials
|
FGFR1 fusion
|
Cholangiocarcinoma
|
FGFR1 fusion
|
Cholangiocarcinoma
|
Debio 1347 Sensitive: C3 – Early Trials
|
Debio 1347 Sensitive: C3 – Early Trials
|
FGFR1 fusion
|
CNS Tumor
|
FGFR1 fusion
|
CNS Tumor
|
TAS 120 Sensitive: C3 – Early Trials
|
TAS 120 Sensitive: C3 – Early Trials
|